Norris Perne & French LLP Thermo Fisher Scientific Inc. Transaction History

Norris Perne & French LLP

  • $1.3 Billion
  • Q2 2024

A detailed history of Norris Perne & French LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Norris Perne & French LLP holds 36,055 shares of TMO stock, worth $21.6 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
36,055
Previous 35,784 0.76%
Holding current value
$21.6 Million
Previous $20.8 Million 4.14%
% of portfolio
1.54%
Previous 1.59%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
BUY
$541.52 - $599.02 $146,751 - $162,334
271 Added 0.76%
36,055 $19.9 Million
Q1 2024

Apr 16, 2024
SELL
$528.82 - $599.43 $521,416 - $591,037
-986 Reduced 2.68%
35,784 $20.8 Million
Q4 2023

Jan 22, 2024
BUY
$431.41 - $532.94 $4.73 Million - $5.84 Million
10,962 Added 42.48%
36,770 $19.5 Million
Q3 2023

Oct 18, 2023
BUY
$498.29 - $574.41 $112,115 - $129,242
225 Added 0.88%
25,808 $13.1 Million
Q2 2023

Jul 19, 2023
BUY
$508.46 - $591.13 $435,241 - $506,007
856 Added 3.46%
25,583 $13.3 Million
Q1 2023

Apr 20, 2023
SELL
$535.0 - $604.82 $24,610 - $27,821
-46 Reduced 0.19%
24,727 $14.3 Million
Q4 2022

Jan 24, 2023
SELL
$484.71 - $571.37 $347,052 - $409,100
-716 Reduced 2.81%
24,773 $0
Q3 2022

Oct 13, 2022
BUY
$507.19 - $604.49 $110,060 - $131,174
217 Added 0.86%
25,489 $12.9 Million
Q2 2022

Aug 11, 2022
BUY
$500.9 - $612.21 $130,734 - $159,786
261 Added 1.04%
25,272 $13.7 Million
Q1 2022

Apr 26, 2022
BUY
$524.0 - $644.92 $40,872 - $50,303
78 Added 0.31%
25,011 $14.8 Million
Q4 2021

Jan 26, 2022
SELL
$569.0 - $667.24 $519,497 - $609,190
-913 Reduced 3.53%
24,933 $16.6 Million
Q3 2021

Oct 26, 2021
BUY
$509.53 - $609.78 $185,468 - $221,959
364 Added 1.43%
25,846 $14.8 Million
Q2 2021

Jul 20, 2021
SELL
$441.0 - $508.24 $3.65 Million - $4.21 Million
-8,283 Reduced 24.53%
25,482 $12.9 Million
Q1 2021

Apr 30, 2021
SELL
$439.85 - $518.83 $2.74 Million - $3.23 Million
-6,219 Reduced 15.55%
33,765 $15.4 Million
Q4 2020

Jan 27, 2021
SELL
$435.06 - $527.66 $45,246 - $54,876
-104 Reduced 0.26%
39,984 $18.6 Million
Q3 2020

Oct 26, 2020
SELL
$359.77 - $441.52 $48,928 - $60,046
-136 Reduced 0.34%
40,088 $17.7 Million
Q2 2020

Jul 23, 2020
BUY
$275.2 - $362.34 $39,904 - $52,539
145 Added 0.36%
40,224 $14.6 Million
Q1 2020

Apr 16, 2020
SELL
$255.3 - $340.05 $3.65 Million - $4.86 Million
-14,287 Reduced 26.28%
40,079 $11.4 Million
Q4 2019

Jan 22, 2020
BUY
$271.93 - $328.04 $59,008 - $71,184
217 Added 0.4%
54,366 $17.7 Million
Q3 2019

Oct 24, 2019
SELL
$268.46 - $305.43 $441,079 - $501,821
-1,643 Reduced 2.94%
54,149 $15.8 Million
Q2 2019

Jul 19, 2019
BUY
$257.51 - $295.55 $97,853 - $112,309
380 Added 0.69%
55,792 $16.4 Million
Q1 2019

Apr 29, 2019
SELL
$212.17 - $273.72 $213,655 - $275,636
-1,007 Reduced 1.78%
55,412 $15.2 Million
Q4 2018

Jan 28, 2019
SELL
$208.47 - $251.98 $60,456 - $73,074
-290 Reduced 0.51%
56,419 $12.6 Million
Q3 2018

Oct 29, 2018
BUY
$205.57 - $244.32 $33,713 - $40,068
164 Added 0.29%
56,709 $13.8 Million
Q2 2018

Jul 24, 2018
SELL
$203.14 - $219.53 $280,739 - $303,390
-1,382 Reduced 2.39%
56,545 $11.7 Million
Q1 2018

Apr 17, 2018
BUY
$192.98 - $224.11 $37,824 - $43,925
196 Added 0.34%
57,927 $12 Million
Q4 2017

Jan 23, 2018
BUY
$182.03 - $200.37 $807,121 - $888,440
4,434 Added 8.32%
57,731 $11 Million
Q3 2017

Nov 01, 2017
BUY
$171.74 - $194.04 $9.15 Million - $10.3 Million
53,297
53,297 $10.1 Million

Others Institutions Holding TMO

# of Institutions
2,779
Shares Held
340M
Call Options Held
1.42M
Put Options Held
2.15M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $235B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email